These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 982666)

  • 21. TMEM16F is required for phosphatidylserine exposure and microparticle release in activated mouse platelets.
    Fujii T; Sakata A; Nishimura S; Eto K; Nagata S
    Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12800-5. PubMed ID: 26417084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of pH, temperature, and calcium on platelet aggregation: maintenance of environmental pH and platelet function for in vitro studies in plasma stored at 37 degrees C.
    Han P; Ardlie NG
    Br J Haematol; 1974 Mar; 26(3):373-89. PubMed ID: 4854896
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of platelets and platelet-derived material on the activated partial thromboplastin time (Cephotest) coagulation test.
    Mendelsohn EE; Solum NO; Brosstad F
    Scand J Clin Lab Invest; 2005; 65(4):321-32. PubMed ID: 16076687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.
    Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI
    Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid-membrane interactions of platelets, coagulation and the arterial wall at the molecular level. Summary of workshop 2b: lipid-membrane interactions of platelets and coagulation with the arterial wall.
    Smith JB
    Adv Exp Med Biol; 1978; 104():343-9. PubMed ID: 717144
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro blood compatibility of functional group-grafted and heparin-immobilized polyurethanes prepared by plasma glow discharge.
    Kang IK; Kwon OH; Kim MK; Lee YM; Sung YK
    Biomaterials; 1997 Aug; 18(16):1099-107. PubMed ID: 9247347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet aggregation induced by ultrasound under specialized conditions in vitro.
    Miller DL; Nyborg WL; Whitcomb CC
    Science; 1979 Aug; 205(4405):505-7. PubMed ID: 451616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The activated plasma recalcification time. A Measurement encompassing the activated partial thromboplastin time and platelet function, with improved detection of bleeders.
    Vura RC; Speicher CE
    Am J Clin Pathol; 1975 Jul; 64(1):80-6. PubMed ID: 1155378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemostyptic effect of oxidized cellulose on blood platelets.
    Másová L; Rysavá J; Krízová P; Suttnar J; Salaj P; Dyr JE; Homola J; Dostálek J; Myska K; Pecka M
    Sb Lek; 2003; 104(2):231-6. PubMed ID: 14577133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of shear stress on clot structure formation.
    Glover CJ; McIntire LV; Leverett LB; Hellums JD; Brown CH; Natelson EA
    Trans Am Soc Artif Intern Organs; 1974; 20 B():463-8. PubMed ID: 4450297
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolic requirements of contractile force generation in platelet rich plasma - a rheological study.
    Kirkpatrick JP; McIntire LV; Moake JL; Peterson DM
    Biorheology; 1980; 17(5-6):411-8. PubMed ID: 7306692
    [No Abstract]   [Full Text] [Related]  

  • 32. Protracted treatment with phorbol ester modulates J-7 human hepatoma-cell-induced aggregation and coagulation of human platelet-rich plasma.
    Ko FN; Yu SM; Teng CM
    Int J Cancer; 1994 Dec; 59(5):706-11. PubMed ID: 7960244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [ON DISORDERS OF THE 1ST PHASE OF BLOOD COAGULATION IN HEMOPHILIA].
    IZMAILOVA EF; KOTOVSHCHIKOVA MA
    Probl Gematol Pereliv Krovi; 1963 Jun; 8():14-8. PubMed ID: 14070536
    [No Abstract]   [Full Text] [Related]  

  • 34. Fibrinogen interaction with human platelets: effect of other coagulation factors, prostaglandins and platelet inhibitors.
    Al-Mondhiry H; Ballard JO; McGarvey V
    Thromb Res; 1983 Aug; 31(3):415-26. PubMed ID: 20217998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammalian platelet damage in vitro by an ultrasonic therapeutic device.
    Williams AR; Chater BV
    Arch Oral Biol; 1980; 25(3):175-9. PubMed ID: 6994700
    [No Abstract]   [Full Text] [Related]  

  • 36. How to optimize the preparation of leukocyte- and platelet-rich fibrin (L-PRF, Choukroun's technique) clots and membranes: introducing the PRF Box.
    Dohan Ehrenfest DM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Sep; 110(3):275-8; author reply 278-80. PubMed ID: 20727495
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of storage on the expression of platelet membrane phosphatidylserine and the subsequent impacton the coagulant function of stored platelets.
    Shapira S; Friedman Z; Shapiro H; Presseizen K; Radnay J; Ellis MH
    Transfusion; 2000 Oct; 40(10):1257-63. PubMed ID: 11061865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The plasma membrane redox system in human platelet functions and platelet-leukocyte interactions.
    Del Principe D; Frega G; Savini I; Catani MV; Rossi A; Avigliano L
    Thromb Haemost; 2009 Feb; 101(2):284-9. PubMed ID: 19190811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A platelet procoagulant activity associated with platelet shape change.
    Ehrman M; Toth E; Frojmovic M
    J Lab Clin Med; 1978 Sep; 92(3):393-401. PubMed ID: 681825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed-onset of procoagulant signalling revealed by kinetic analysis of COAT platelet formation.
    Alberio L; Ravanat C; Hechler B; Mangin PH; Lanza F; Gachet C
    Thromb Haemost; 2017 Jun; 117(6):1101-1114. PubMed ID: 28382366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.